Crinetics Pharmaceuticals, Inc. — Form D

Crinetics Pharmaceuticals, Inc. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2024-03-11. The offering totals $350.0M, of which $350.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (30)

Showing 25 of 30 people.

NameRoleLocation
CAMILLE SCOTT BEDROSIAN, M.D.DirectorSAN DIEGO, CA
ROGERIO VIVALDI COELHO, M.D.DirectorSAN DIEGO, CA
CAREN SCOTT DEARDORFDirectorSAN DIEGO, CA
MATTHEW SCOTT FUSTDirectorSAN DIEGO, CA
WESTON SCOTT NICHOLS, PhDDirectorSAN DIEGO, CA
STEPHANIE SCOTT OKEYDirectorSAN DIEGO, CA
RICHARD SCOTT STRUTHERS, PhDDirectorSAN DIEGO, CA
WENDELL SCOTT WIERENGA, PhDDirectorSAN DIEGO, CA
STEPHEN VIVALDI BETZExecutive OfficerSAN DIEGO, CA
JAMES VIVALDI HASSARDExecutive OfficerSAN DIEGO, CA
JEFF VIVALDI KNIGHTExecutive OfficerSAN DIEGO, CA
DANA VIVALDI PIZZUTIExecutive OfficerSAN DIEGO, CA
RICHARD SCOTT STRUTHERS, PhDExecutive OfficerSAN DIEGO, CA
MARC SCOTT WILSONExecutive OfficerSAN DIEGO, CA
Matthew K FustDirectorMenlo Park, CA
Mason Scott Freeman, M.D.DirectorSan Diego, CA
Wendell Scott Wierenga, Ph.DDirectorSan Diego, CA
Richard Scott Struthers, Ph.DDirectorSan Diego, CA
Richard Scott Struthers, Ph.DExecutive OfficerSan Diego, CA
Steve Scott Kaldor, Ph.DDirectorSan Diego, CA
Weston K Nichols, Ph.DDirectorSan Diego, CA
YunFei F ZhuExecutive OfficerSan Diego, CA
Steve Scott KaldorDirectorSan Diego, CA
Mason Scott FreemanDirectorSan Diego, CA
Wendell Scott WierengaDirectorSan Diego, CA

Other filings by this issuer (2)

FiledFormOfferingSold
2018-02-23D$65.0M$60.0M
2015-11-16D$40.0M$18.0M

More